Related Experiment Video

Updated: Jan 4, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.0K

MicroRNA-424-5p inhibits the development of non-small cell LCa by binding to ITGB1

Z-L Xu1, M Zhang, S-X Chen

  • 1Department of Respiratory Medicine, The First People's Hospital of Fuyang, Hangzhou, China. 283112534@qq.com.

European Review for Medical and Pharmacological Sciences
|November 8, 2019
PubMed
Abstract

Insights

MicroRNA-424-5p is downregulated in non-small cell lung cancer (NSCLC), inhibiting tumor growth and promoting apoptosis. Its low expression correlates with advanced NSCLC, suggesting therapeutic potential.

Area of Science:

  • Molecular Oncology
  • Cancer Biology
  • MicroRNA Therapeutics

Background:

  • Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide.
  • Dysregulation of microRNAs is implicated in the pathogenesis of various cancers, including NSCLC.
  • Identifying novel molecular targets is crucial for developing effective NSCLC treatments.

Purpose of the Study:

  • To investigate the role of microRNA-424-5p in NSCLC proliferation and apoptosis.
  • To explore the regulatory relationship between microRNA-424-5p and its target gene, integrin beta-1 (ITGB1).
  • To assess the potential of microRNA-424-5p as a biomarker and therapeutic agent for NSCLC.

Main Methods:

  • Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) to measure microRNA-424-5p and ITGB1 expression in NSCLC tissues and cell lines.
  • In vitro functional assays (CCK-8, colony formation, EdU, flow cytometry) to assess the impact of microRNA-424-5p modulation on NSCLC cell behavior.
  • Luciferase reporter gene assays and cell recovery experiments to elucidate the interaction between microRNA-424-5p and ITGB1.

Main Results:

  • MicroRNA-424-5p expression was significantly reduced in NSCLC tissues compared to adjacent normal tissues.
  • Lower microRNA-424-5p levels correlated with higher pathological stage in NSCLC patients.
  • Overexpression of microRNA-424-5p suppressed NSCLC cell proliferation and induced apoptosis, while its inhibition promoted these processes.
  • ITGB1 expression was upregulated in NSCLC and inversely correlated with microRNA-424-5p levels.
  • ITGB1 overexpression partially reversed the anti-proliferative and pro-apoptotic effects of microRNA-424-5p mimics.

Conclusions:

  • MicroRNA-424-5p acts as a tumor suppressor in NSCLC by inhibiting cell proliferation and promoting apoptosis.
  • The microRNA-424-5p/ITGB1 axis plays a significant role in the malignant progression of NSCLC.
  • MicroRNA-424-5p holds promise as a prognostic biomarker and a potential therapeutic target for NSCLC.

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.0K
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method

Published on: October 7, 2025

289

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.7K